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whether the combined results obtained with the
different primers were as discriminative as
those obtained with the techniques described
above, as has been found by others, including
ourselves.
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We thank Dr Esteban and colleagues for their
interesting comments. We had the opportunity
to read their article [4], and although it also
evaluated other rapidly growing mycobacteria,
our response here will be limited to Mycobacte-
rium fortuitum. In brief, they investigated 16 M.
fortuitum isolates using four different primers
and a single method, RAPD, modified from the
original protocol described by Zhang et al. [2];
however, ERIC-PCR or PFGE were not used.
Consequently, we disagree with their claim that
our results are not consistent with their own
experience in this area, as this is limited to
RAPD. We agree that RAPD analysis with
different primer sets may improve clonality
analysis, as described for Mycobacterium absces-
sus by Zhang et al. [2], although RAPD has
never been adequately validated for any of the
rapid growing mycobacteria as recommended
by the consensus guidelines of the ESCMID
Study Group for Epidemiological Markers [7].
We also tested M. fortuitum outbreak isolates
and unrelated control strains with primer OPA-
2, but we did not follow the protocol of Zhang
et al. [2], as this has not been validated for
M. fortuitum. When a combined analysis was
performed with profiles obtained with RAPD1
and OPA2, control strain C6, epidemiologically
unrelated to the outbreak, still clustered with
the outbreak isolates. This is why we stated that
PFGE and ERIC-PCR performed better than
RAPD in terms of discriminating among the
group of isolates and strains that we analysed
[1].
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